New York-based Nuvation Bio (NYSE: NUVB) today announced positive pooled data from the pivotal Phase II TRUST-I and TRUST-II ...

US pharma giant Merck & Co announced positive overall survival (OS) results from the final analysis of the Phase III ...

Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors, with the news sending the Canada-based ...

At the ESMO Congress 2024, ICON shared survey findings highlighting concerns among oncology professionals about the impact of ...

The National Institute for Health and Care Excellence (NICE) has recommended access Vabysmo (faricimab) for the treatment of ...

Nona Biosciences and Umoja Biopharma have entered a multi-target antibody discovery collaboration to develop off-the-shelf CAR-T cell therapies using Nona's fully human heavy chain only antibody (HCAb ...

Among the first presentations at the European Society for Medical Oncology (ESMO) meeting that kicked off today, were results ...

Women’s health focussed company Organon China today revealed that it has entered into license and supply agreements with ...

Eli Lilly is investing $1 billion to expand its Limerick, Ireland site for biologic active ingredients, including Alzheimer's treatment components. This adds to a $2 billion total investment in ...

On Thursday, the US Food and Drug Administration released a Drug Safety Communication warning that Veozah (fezolinetant), ...

GSK announced positive Phase II results for its mRNA seasonal influenza vaccine, showing strong immune responses against ...

Fulcrum Therapeutics' shares fell 61% after its Phase III REACH trial for losmapimod in facioscapulohumeral muscular ...